B-325 APOE Genetic Testing and E4 Allele Frequency in a Clinical Population: Implications for Alzheimer’s Disease Risk Stratification
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder worldwide and represents a major public health challenge driven by population aging. It is estimated that more than 50 million people currently live with dementia, with AD accounting for 60–70% of cases, and projections exceeding 150 millio...